Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
February 21, 2018
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
Anne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
British Journal of Cancer
|
December 15, 2015
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
Anne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 2, 2018
Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution
Joy Bacrie, Marc Laurans, Pauline Iorio, et al.
Cancers
|
May 14, 2022
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals
Clelia Chalumeau, Matthieu Carton, Alexandre Eeckhoutte, et al.
Oncogene
|
October 19, 2002
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
Elizabeth Turpin, Ivan Bièche, Philippe Bertheau, et al.
Molecular Cancer
|
March 1, 2011
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
Ivan Bièche, Sophie Vacher, François Lallemand, et al.
Plos One
|
January 24, 2019
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach
Enora Laas, Anne-Sophie Hamy, Anne-Sophie Michel, et al.
JAMA Network Open
|
August 19, 2024
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis
Marie Lange, Justine Lequesne, Agnes Dumas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer
Romain-David Seban, Laurence Champion, Alexandre De Moura, et al.
Journal of Translational Medicine
|
April 18, 2024
Mutational landscape of inflammatory breast cancer
François Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
February 21, 2018
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
Anne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
British Journal of Cancer
|
December 15, 2015
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
Anne-Sophie Hamy, Lisa Belin, Hélène Bonsang-Kitzis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 2, 2018
Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution
Joy Bacrie, Marc Laurans, Pauline Iorio, et al.
Cancers
|
May 14, 2022
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals
Clelia Chalumeau, Matthieu Carton, Alexandre Eeckhoutte, et al.
Oncogene
|
October 19, 2002
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
Elizabeth Turpin, Ivan Bièche, Philippe Bertheau, et al.
Molecular Cancer
|
March 1, 2011
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
Ivan Bièche, Sophie Vacher, François Lallemand, et al.
Plos One
|
January 24, 2019
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach
Enora Laas, Anne-Sophie Hamy, Anne-Sophie Michel, et al.
JAMA Network Open
|
August 19, 2024
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis
Marie Lange, Justine Lequesne, Agnes Dumas, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer
Romain-David Seban, Laurence Champion, Alexandre De Moura, et al.
Journal of Translational Medicine
|
April 18, 2024
Mutational landscape of inflammatory breast cancer
François Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Page
of 10